Cleared Traditional

K925826 - ENCORE THYROGLOBULIN IGE, IGA AND IGM EIA
(FDA 510(k) Clearance)

K925826 · Clark Laboratories, Inc. · Immunology
Jan 1993
Decision
71d
Days
Class 2
Risk

K925826 is an FDA 510(k) clearance for the ENCORE THYROGLOBULIN IGE, IGA AND IGM EIA. This device is classified as a System, Test, Thyroid Autoantibody (Class II — Special Controls, product code JZO).

Submitted by Clark Laboratories, Inc. (Blairstown, US). The FDA issued a Cleared decision on January 26, 1993, 71 days after receiving the submission on November 16, 1992.

This device falls under the Immunology FDA review panel. Regulated under 21 CFR 866.5870.

Submission Details

510(k) Number K925826 FDA.gov
FDA Decision Cleared SESE
Date Received November 16, 1992
Decision Date January 26, 1993
Days to Decision 71 days
Submission Type Traditional
Review Panel Immunology (IM)
Summary Summary PDF

Device Classification

Product Code JZO — System, Test, Thyroid Autoantibody
Device Class Class II — Special Controls
CFR Regulation 21 CFR 866.5870

Similar Devices — JZO System, Test, Thyroid Autoantibody

All 91
ADVIA Centaur Anti-Thyroid Peroxidase II
K250250 · Siemens Healthcare Diagnostics, Inc. · Oct 2025
Access TPO Antibody
K240469 · Beckman Coulter, Inc. · Aug 2024
Access Thyroglobulin Antibody II
K213517 · Beckman Coulter, Inc. · Sep 2023
Elecsys Anti-Tg
K222610 · Roche Diagnostics · Sep 2023
Elecsys Anti-TSHR
K193313 · Roche Diagnostics · Feb 2020
EliA anti-TG Immunoassay, EliA anti-TPO Immunoassay, EliA Thyroid Positive Control 250, EliA Thyroid Positive Control 2500/5000
K151799 · Phadia AB · Mar 2016